Activation of mesolimbic dopamine function by phencyclidine is enhanced by 5-HT(2C/2B) receptor antagonists: Neurochemical and behavioural studies

Neuropharmacology

Volumn 39, Issue 12, 2000, Pages 2318-2328

  Hutson, P H ^a   Barton, C L ^a   Jay, M ^a   Blurton, P ^a   Burkamp, F ^a   Clarkson, R ^a   Bristow, L J ^a  

^a NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

Author keywords

5 HT(2C) receptors; Dialysis; Dopamine; Locomotor activity; MK 801; Nucleus accumbens; PCP

Indexed keywords

1,2,3,5 TETRAHYDRO 5 METHYL 1 (3 PYRIDYLCARBAMOYL)PYRROLO[2,3 F]INDOLE; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHENCYCLIDINE; SEROTONIN 2B RECEPTOR ANTAGONIST; SEROTONIN 2C ANTAGONIST; SEROTONIN 2C RECEPTOR; SEROTONIN ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; HYPERACTIVITY; LOCOMOTION; MALE; MESOLIMBIC DOPAMINERGIC SYSTEM; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; RECEPTOR OCCUPANCY; SCHIZOPHRENIA; STATISTICAL ANALYSIS;

AMINOPYRIDINES; ANIMALS; BEHAVIOR, ANIMAL; BRAIN CHEMISTRY; DIZOCILPINE MALEATE; DOPAMINE; DOPAMINE AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; INDOLES; LIMBIC SYSTEM; MALE; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; PHENCYCLIDINE; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2B; RECEPTOR, SEROTONIN, 5-HT2C; RECEPTORS, SEROTONIN; SEROTONIN ANTAGONISTS; STIMULATION, CHEMICAL;

EID: 0033879531     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(00)00089-7     Document Type: Article

References (55)

1. 2C receptor protein in human and rat brain using specific antisera. Neuropharmacology. 34:1995;1635-1645.
2. Arnt J., Skarsfeldt T. Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence. Neuropsychopharmacology. 18:1998;63-101.
3. Azmitia E.C., Segal M. An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. Journal of Comparative Neurology. 179:1978;641-668.
4. 2C/2B receptor antagonist SB 221284. British Journal of Pharmacology. 128:1999;6P.
5. Bristow L.J., Hutson P.H., Thorn L., Tricklebank M.D. The glycine/NMDA receptor antagonist, R-(+)-HA-966 blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK-801) in rodents. British Journal of Pharmacology. 108:1993;1156-1163.
6. 2C/2B receptor antagonists as potential anxiolytic agents: synthesis, quantitative structure-activity relationships and molecular modeling of substituted 1-(3-Pyridylcarbamoyl)indolines. Journal of Medicinal Chemistry. 41:1998;1598-1612.
7. 2A receptor antagonist MDL100907 counteracts the psychomotor stimulation ensuing manipulations with monoaminergic, glutaminergic or muscarinic neurotransmission in the mouse - implications for psychosis. Journal of Neural Transmission [Gen Sect]. 100:1995;225-237.
8. 2B/2C receptor subtypes in the control of accumbal and striatal dopamine release elicited in vivo by dorsal raphe nucleus electrical stimulation. Journal of Neurochemistry. 73:1999;1033-1042.
9. 2C/2B receptors enhances dopamine release in the rat nucleus accumbens. Neuropharmacology. 37:1998;265-272.
10. 2C receptor antagonist increases dopaminergic transmission in the mesolimbic system. Neuropharmacology. 38:1999;1195-1205.
11. 2 receptor antagonist. British Journal of Pharmacology. 105:1992;27-36.
12. 2 receptors: microdialysis studies in the awake and anaesthetised rat. British Journal of Pharmacology. 33:1994;411-421.
13. 2B receptor protein in the rat central nervous system. Neuroscience. 76:1997;323-329.
14. 2C receptor messenger RNA in the basal ganglia of adult rats. Journal of Comparative Neurology. 384:1997;233-247.
15. Flanigan T.P., Reavley A.C., Carey J.E., Leslie R.A. Evidence for expression of the 5-HT2B receptor mRNA in rat brain. British Journal of Pharmacology. 114:1995;369P.
16. French E.D., Mura A., Wang T. MK-801, phencyclidine (PCP) and PCP-like drugs increase burst firing rate in rat A10 dopamine neurones: comparison to competitive NMDA antagonists. Synapse. 13:1993;108-116.
17. 2C/2B receptor antagonist SB 221284 enhances the behavioural and neurochemical effects of morphine in mice. British Journal of Pharmacology. 126:1999;237P.
18. Gleason S.D., Shannon H.E. Blockade of phencyclidine induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice. Psychopharmacology. 129:1997;79-84.
19. Guan X.M., McBride W.J. Serotonin microinfusion into the ventral tegmental area increases accumbens dopamine release. Brain Research Bulletin. 23:1989;541-547.
20. Hernandez L., Auerbach S., Hoebel B.G. Phencyclidine (PCP) injected in the nucleus accumbens increases extracellular dopamine and serotonin as measured by microdialysis. Life Science. 42:1988;1713-1723.
21. Herve D., Simon H., Blanc G., Lisoprawski A., Le Moal J., Glowinski J., Tassin J.P. Increased utilisation of dopamine in the nucleus accumbens but not in the cerebral cortex after dorsal raphe lesion in the rat. Neuroscience Letters. 15:1979;127-133.
22. Hondo H., Yonezawa Y., Nakahara T., Nakamura K., Hirano M., Uchimura H., Tashiro N. Effects of phencyclidine on dopamine release in the rat prefrontal cortex: an in vivo microdialysis study. Brain Research. 633:1994;337-342.
23. Hutson P.H., Bristow L.J., Thorn L., Tricklebank M.D. R-(+)-HA-966, a glycine/NMDA receptor antagonist selectively blocks the activation of the mesolimbic system by amphetamine. British Journal of Pharmacology. 103:1991;2037-2044.
24. Javitt D.C., Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. American Journal of Psychiatry. 148:1991;1301-1307.
25. Jentsch J.D., Tran A., Taylor J.R., Roth R.H. Prefrontal cortical involvement in phencyclidine-induced activation of the mesolimbic dopamine system: behavioural and neurochemical evidence. Psychopharmacology. 138:1998;89-95.
26. 2A antagonist with a favourable CNS safety profile. Journal of Pharmacology and Experimental Therapeutics. 277:1996;968-981.
27. Kelland M.D., Freeman A.S., Rubin J., Chiodo L.A. Ascending afferent regulation of rat midbrain dopamine neurons. Brain Research Bulletin. 31:1993;539-546.
28. 1C receptors. British Journal of Pharmacology. 94:1988;137-147.
29. 2C receptor antagonist. Neuropharmacology. 36:1997;609-620.
30. Kim J.S., Kornhuber H.H., Schmid-Burgk W., Holzmueller B. Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia. Neuroscience Letters. 20:1980;379-382.
31. Koek W., Woods J.H., Winger G.D. MK-801 a proposed non-competitive antagonist of excitatory amino acid transmission, produces phencyclidine-like behavioural effects in pigeons, rats and rhesus monkeys. Journal of Pharmacology and Experimental Therapeutics. 245:1988;969-974.
32. Liljequist S., Ossowska K., Grabowska-Anden M., Anden N.E. Effect of the NMDA receptor antagonist MK-801 on locomotor activity and on the metabolism of dopamine in various brain areas of mice. European Journal of Pharmacology. 195:1991;55-61.
33. 2C receptors inhibit the activity of mesocortical and mesolimbic dopaminergic pathways: a combined dialysis and electrophysiological analysis. Society for Neuroscience Abstracts. 23:1997;975.
34. Loscher W., Annies R., Honack D. The N-methyl-D-aspartate receptor antagonist MK-801 induces increases in dopamine and serotonin metabolism in several brain regions of rats. Neuroscience Letters. 128:1991;191-194.
35. Loscher W., Honack D. The behavioural effects of MK-801 in rats: involvement of dopaminergic, serotonergic and noradrenergic systems. European Journal of Pharmacology. 215:1992;199-208.
36. Mathe J.M., Nomikos G.G., Hildebrand B.E., Hertel P., Svensson T.H. Prazosin inhibits MK-801 induced hyperlocomotion and dopamine release in the nucleus accumbens. European Journal of Pharmacology. 309:1996;1-11.
37. 2A receptors. European Journal of Pharmacology. 280:1995;R9-R11.
38. 2C/2B antagonist SB 206553 on hyperactivity induced by cocaine. Neuropsychopharmacology. 20:1999;556-564.
39. Meltzer H.Y., Nash J.F. Effects of antipsychotic drugs on serotonin receptors. Pharmacology Reviews. 43:1991;587-604.
40. Mengod G., Nguyen H., Le H., Waeber C., Lubbert H., Palacios J.M. The distribution and cellular localisation of the serotonin 1C receptor mRNA in the rodent brain examined by in situ hybridisation histochemistry. Comparison with receptor binding distribution. Neuroscience. 35:1990;577-591.
41. 2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo. Neuropharmacology. 37:1998;953-955.
42. Murase S., Mathe J.M., Grenhoff J., Svensson T.H. Effects of dizocilpine (MK-801) on rat midbrain dopamine cell activity: differential actions on firing pattern related to anatomical localization. Journal of Neural Transmission [General Sect]. 91:1993;13-25.
43. 2A receptor antagonist MDL100907 attenuates the behavioural and neurochemical effects of PCP in rodents. British Journal of Pharmacology. 123:1998;241P.
44. Parsons L.H., Justice J.B. Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis. Brain Research. 606:1993;195-199.
45. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1986;Academic Press, Sydney, Australia.
46. Pazos A., Cortes R., Palacios J.M. Quantitative autoradiographic mapping of serotonin receptors in the rat brain - II. Serotonin-2 receptors. Brain Research. 346:1985;231-249.
47. 2C receptors. Molecular Brain Research. 23:1994;163-178.
48. Prisco S., Pagannone S., Esposito E. Serotonin-dopamine interaction in the rat ventral tegmental area: an electrophysiological study in vivo. Journal of Pharmacology and Experimental Therapeutics. 271:1994;83-90.
49. 2A receptor blockade. Journal of Pharmacology and Experimental Therapeutics. 277:1996;1541-1549.
50. Tiedtke P.I., Bischoff C., Schimidt W.J. MK-801 induced stereotypy and its antagonism by neuroleptic drugs. Journal of Neural Transmission. 81:1990;173-182.
51. Wang T., French E.D. Electrophysiological evidence for the existence of NMDA and non-NMDA receptors on rat ventral tegmental dopamine neurons. Synapse. 13:1993;270-277.
52. 1 receptors. Brain Research. 622:1993;325-329.
53. Yan Q.-S., Reith M.E.A., Jobe P.C., Dailey J.W. Dizocilpine (MK-801) increases not only dopamine but also serotonin and norepinephrine transmissions in the nucleus accumbens as measured by microdialysis in freely moving rats. Brain Research. 765:1997;149-158.
54. Yoshida M., Yokoo H., Mizoguchi K., Tanaka T., Emoto H., Tanaka M. NMDA and MK801 induced changes in dopamine release are attenuated in kainic acid lesioned nucleus accumbens of conscious rats: an in vivo microdialysis study. Brain Research. 786:1998;226-229.
55. Zhang J., Chiodo L.A., Freeman A.S. Electrophysiological effects of MK-801 on rat nigrostriatal and mesoaccumbal dopaminergic neurons. Brain Research. 590:1992;153-163.